PET Imaging of Hepatocellular Carcinoma Using ZD2-( 68 Ga-NOTA).

Olga SergeevaYifan ZhangSongqi GaoE Ricky ChanMaxim SergeevRenuka IyerSandra SextonNorbert AvrilZheng-Rong LuZhenghong Lee

Published in: Journal of hepatocellular carcinoma (2023)

We have showed the viability of using the ZD2 short peptide radioligand targeting EDB-FN in liver tumor tissue for PET imaging of HCC, which can potentially impact the clinical care for HCC patients.

Keyphrases

pet imaging
end stage renal disease
positron emission tomography
ejection fraction
healthcare
chronic kidney disease
newly diagnosed
pet ct
palliative care
computed tomography
pain management
cancer therapy
drug delivery
patient reported outcomes
chronic pain
health insurance